title: Angiotensin II regulates ACE and ACE2 in neurons through p38 mitogen-activated protein kinase and extracellular signal-regulated kinase 1/2 signaling.
abstract: Brain ANG II plays an important role in modulating sympathetic function and homeostasis. The generation and degradation of ANG II are carried out, to a large extent, through the angiotensin-converting enzyme (ACE) and ACE2, respectively. In disease states, such as hypertension and chronic heart failure, central expression of ACE is upregulated and ACE2 is decreased in central sympathoregulatory neurons. In this study, we determined the expression of ACE and ACE2 in response to ANG II in a neuronal cell culture and the subsequent signaling mechanism(s) involved. A mouse catecholaminergic neuronal cell line (CATH.a) was treated with ANG II (30, 100, and 300 nM) for 24 h, and protein expression was determined by Western blot analysis. ANG II induced a significant dose-dependent increase in ACE and decrease in ACE2 mRNA and protein expression in CATH.a neurons. This effect was abolished by pretreatment of the cells with the p38 MAPK inhibitor SB-203580 (10 μM) 30 min before administration of ANG II or the ERK1/2 inhibitor U-0126 (10 μM). These data suggest that ANG II increases ACE and attenuates ACE2 expression in neurons via the ANG II type 1 receptor, p38 MAPK, and ERK1/2 signaling pathways.
authors.affiliation: Department of Cellular and Integrative Physiology, University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: Liang
authors.initials: L
authors.lastname: Xiao
authors.forename: Karla K V
authors.initials: KK
authors.lastname: Haack
authors.forename: Irving H
authors.initials: IH
authors.lastname: Zucker
mesh_terms: D000804:Angiotensin II / Q000378:metabolism*; D000085962:Angiotensin-Converting Enzyme 2; D000818:Animals; D015153:Blotting, Western; D001921:Brain / Q000502:physiology; D002460:Cell Line; D005455:Fluorescent Antibody Technique; D020935:MAP Kinase Signaling System / Q000502:physiology*; D051379:Mice; D018613:Microscopy, Confocal; D009474:Neurons / Q000378:metabolism*; D007703:Peptidyl-Dipeptidase A / Q000096:biosynthesis*; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D000804:Angiotensin II; D007703:Peptidyl-Dipeptidase A; C000705328:Ace2 protein, mouse; D000085962:Angiotensin-Converting Enzyme 2
keywords: angiotensin; converting enzyme; signaling
references.citation: Hypertension. 2009 Feb;53(2):210-6
references.pmid: 19124678
references.citation: Ann N Y Acad Sci. 2001 Jun;940:431-43
references.pmid: 11458699
references.citation: Basic Res Cardiol. 2011 Nov;106(6):1069-85
references.pmid: 22124756
references.citation: Circ Res. 2005 Oct 14;97(8):772-80
references.pmid: 16151022
references.citation: Circ Res. 2001 Oct 12;89(8):661-9
references.pmid: 11597988
references.citation: J Appl Physiol (1985). 2010 Apr;108(4):923-32
references.pmid: 20093667
references.citation: Circ Res. 2008 Jul 18;103(2):186-93
references.pmid: 18566341
references.citation: J Renin Angiotensin Aldosterone Syst. 2012 Sep;13(3):341-52
references.pmid: 22526820
references.citation: Hypertens Res. 2001 Mar;24(2):179-87
references.pmid: 11325078
references.citation: Neuroscience. 1987 Feb;20(2):615-27
references.pmid: 3035425
references.citation: Am J Physiol Heart Circ Physiol. 2006 Aug;291(2):H687-93
references.pmid: 16582019
references.citation: J Neurochem. 2008 Dec;107(6):1482-94
references.pmid: 19014390
references.citation: Neuroendocrinology. 1985 Jan;40(1):2-24
references.pmid: 3969196
references.citation: Hypertension. 2007 Dec;50(6):1093-8
references.pmid: 17984366
references.citation: J Hypertens. 2001 Mar;19(3 Pt 2):553-9
references.pmid: 11327629
references.citation: Hypertension. 2013 Jan;61(1):253-8
references.pmid: 23150519
references.citation: Am J Physiol Cell Physiol. 2010 Sep;299(3):C561-9
references.pmid: 20554912
references.citation: Am J Physiol Regul Integr Comp Physiol. 2007 Jan;292(1):R373-81
references.pmid: 16946085
references.citation: Endocrinology. 2007 May;148(5):2453-7
references.pmid: 17303661
references.citation: Hypertension. 2001 Nov;38(5):1087-92
references.pmid: 11711502
references.citation: Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1557-66
references.pmid: 19717736
references.citation: Mol Endocrinol. 2006 May;20(5):953-70
references.pmid: 16141358
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8258-63
references.pmid: 12829792
references.citation: Am J Physiol. 1999 Sep;277(3):L440-8
references.pmid: 10484450
references.citation: Hypertension. 2012 Mar;59(3):621-6
references.pmid: 22311897
references.citation: Circ Res. 2006 Oct 27;99(9):1004-11
references.pmid: 17008603
references.citation: Endocrinology. 2006 Oct;147(10):4646-54
references.pmid: 16809450
references.citation: Oncogene. 2004 Oct 18;23(48):7906-9
references.pmid: 15489908
references.citation: Am J Physiol Heart Circ Physiol. 2009 May;296(5):H1425-33
references.pmid: 19286949
references.citation: Kidney Int. 2004 Mar;65(3):972-81
references.pmid: 14871417
references.citation: Am J Pathol. 2008 May;172(5):1174-83
references.pmid: 18403595
references.citation: Hypertension. 2012 Jan;59(1):113-21
references.pmid: 22106405
references.citation: Brain Res. 1984 Nov 12;321(2):209-15
references.pmid: 6388733
references.citation: J Hypertens. 1998 Dec;16(12 Pt 2):2027-37
references.pmid: 9886893
references.citation: Physiol Rev. 1994 Apr;74(2):323-64
references.pmid: 8171117
references.citation: J Comp Neurol. 1990 Jan 8;291(2):179-94
references.pmid: 2153714
references.citation: Am J Physiol Lung Cell Mol Physiol. 2009 Oct;297(4):L631-40
references.pmid: 19592460
references.citation: Am J Physiol Heart Circ Physiol. 2004 May;286(5):H1665-71
references.pmid: 14693687
references.citation: ScientificWorldJournal. 2009 Jun 30;9:522-35
references.pmid: 19578709
references.citation: Am J Hypertens. 2011 Jun;24(6):724-30
references.pmid: 21394088
references.citation: Exp Physiol. 2008 May;93(5):676-84
references.pmid: 18310259